Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thoma Cressey Equity Partners was a prominent private equity firm that operated with a focus on the 'buy-and-build' investment strategy. The firm was particularly active in the healthcare, software, and business services sectors, seeking to consolidate fragmented industries through platform acquisitions. Founded in 1998 as a successor to Golder, Thoma, Cressey, Rauner, it managed several billion dollars in capital across multiple funds. In 2008, the firm's partners decided to split the entity into two specialized firms to better focus on their respective core competencies. This resulted in the formation of Thoma Bravo, which focuses on software and technology, and Cressey & Company, which focuses on healthcare services. During its existence, Thoma Cressey was a key financier for numerous healthcare delivery and medical technology organizations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thoma Cressey Equity Partners.